A Study on the Safety and Effectiveness of Tislelizumab Combined With Axitinib for Neoadjuvant Treatment of ccRCC
Clinical trial NCT05172440 · UNKNOWN
Trial details
- NCT number
- NCT05172440
- Sponsor
- Hongqian Guo
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-09
- Primary completion
- 2023-11-20
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.